Product NDC: | 60977-451 |
Proprietary Name: | Reglan |
Non Proprietary Name: | METOCLOPRAMIDE HYDROCHLORIDE |
Active Ingredient(s): | 5 mg/mL & nbsp; METOCLOPRAMIDE HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60977-451 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017862 |
Marketing Category: | NDA |
Start Marketing Date: | 20101209 |
Package NDC: | 60977-451-02 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 CARTON (60977-451-02) > 10 mL in 1 VIAL, SINGLE-DOSE (60977-451-71) |
NDC Code | 60977-451-02 |
Proprietary Name | Reglan |
Package Description | 25 VIAL, SINGLE-DOSE in 1 CARTON (60977-451-02) > 10 mL in 1 VIAL, SINGLE-DOSE (60977-451-71) |
Product NDC | 60977-451 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | METOCLOPRAMIDE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20101209 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |